Netabolics Company

Netabolics empowers drug discovery project teams with a cloud platform for AI-enabled predictive biosimulations.

Investors

Industry: AI, Early Drug Development
Headquarters: Rome, Lazio, Italy
Founded Date: 2020-06-30
Investors Number: 1
Total Funding: 30000
Estimated Revenue: $1M to $10M
Last Funding Date: 2020-11-09
Last Funding Type: Grant

Visit Website
Register and Claim Ownership